Improving the <i>ex vivo</i> expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors.

Qiu, Chenli; Wang, Jing; Zhu, Lingyan; Cheng, Xiaobo; Xia, Bili; Jin, Yanling; Qin, Ran; Zhang, LinXia; Hu, Huiliang; Yan, Jia; Zhao, Chen; Zhang, Xiaoyan; Xu, Jianqing

Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors.

Qiu, Chenli; Wang, Jing; Zhu, Lingyan; Cheng, Xiaobo; Xia, Bili; Jin, Yanling; Qin, Ran; Zhang, LinXia; Hu, Huiliang; Yan, Jia; Zhao, Chen; Zhang, Xiaoyan; Xu, Jianqing.

Afiliação

Qiu C; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Wang J; Zhongshan Hospital & Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Zhu L; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Cheng X; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Xia B; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jin Y; Clinical Research Center, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China.
Qin R; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zhang L; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Hu H; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Yan J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zhao C; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Zhang X; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Xu J; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.